General Information of Drug Off-Target (DOT) (ID: OTR3TNTJ)

DOT Name Steroid receptor-associated and regulated protein (SRARP)
Synonyms Estrogen receptor-related factor; ER-related factor; Steroid receptor-regulated protein
Gene Name SRARP
Related Disease
Advanced cancer ( )
Breast cancer ( )
Breast carcinoma ( )
Breast neoplasm ( )
Estrogen-receptor positive breast cancer ( )
Neoplasm ( )
UniProt ID
SRARP_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF15547
Sequence
MAPSEDPRDWRANLKGTIRETGLETSSGGKLAGHQKTVPTAHLTFVIDCTHGKQLSLAAT
ASPPQAPSPNRGLVTPPMKTYIVFCGENWPHLTRVTPMGGGCLAQARATLPLCRGSVASA
SFPVSPLCPQEVPEAKGKPVKAAPVRSSTWGTVKDSLKALSSCVCGQAD
Function May regulate the transcriptional function of androgen and estrogen receptors.
Tissue Specificity Expressed in breast tumors with a higher expression level in estrogen receptor-positive cancers .

Molecular Interaction Atlas (MIA) of This DOT

6 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Strong Posttranslational Modification [1]
Breast cancer DIS7DPX1 Strong Altered Expression [2]
Breast carcinoma DIS2UE88 Strong Altered Expression [2]
Breast neoplasm DISNGJLM Strong Altered Expression [3]
Estrogen-receptor positive breast cancer DIS1H502 Strong Biomarker [4]
Neoplasm DISZKGEW moderate Altered Expression [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
6 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Steroid receptor-associated and regulated protein (SRARP). [5]
Quercetin DM3NC4M Approved Quercetin decreases the expression of Steroid receptor-associated and regulated protein (SRARP). [6]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of Steroid receptor-associated and regulated protein (SRARP). [7]
Leflunomide DMR8ONJ Phase 1 Trial Leflunomide increases the expression of Steroid receptor-associated and regulated protein (SRARP). [9]
Bisphenol A DM2ZLD7 Investigative Bisphenol A affects the expression of Steroid receptor-associated and regulated protein (SRARP). [11]
Coumestrol DM40TBU Investigative Coumestrol decreases the expression of Steroid receptor-associated and regulated protein (SRARP). [12]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Steroid receptor-associated and regulated protein (SRARP). [8]
PMID28870136-Compound-52 DMFDERP Patented PMID28870136-Compound-52 decreases the phosphorylation of Steroid receptor-associated and regulated protein (SRARP). [10]
------------------------------------------------------------------------------------

References

1 SRARP and HSPB7 are epigenetically regulated gene pairs that function as tumor suppressors and predict clinical outcome in malignancies.Mol Oncol. 2018 May;12(5):724-755. doi: 10.1002/1878-0261.12195. Epub 2018 Apr 16.
2 ERRF sensitizes ERBB2-positive breast cancer cells to lapatinib treatment likely by attenuating MCL1 and ERBB2 expression.Oncotarget. 2017 May 30;8(22):36054-36066. doi: 10.18632/oncotarget.16425.
3 C1orf64 is a novel androgen receptor target gene and coregulator that interacts with 14-3-3 protein in breast cancer.Oncotarget. 2017 May 11;8(34):57907-57933. doi: 10.18632/oncotarget.17826. eCollection 2017 Aug 22.
4 Role of ERRF, a novel ER-related nuclear factor, in the growth control of ER-positive human breast cancer cells.Am J Pathol. 2012 Mar;180(3):1189-1201. doi: 10.1016/j.ajpath.2011.11.025.
5 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
6 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
7 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
8 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
9 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
10 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
11 Comprehensive analysis of transcriptomic changes induced by low and high doses of bisphenol A in HepG2 spheroids in vitro and rat liver in vivo. Environ Res. 2019 Jun;173:124-134. doi: 10.1016/j.envres.2019.03.035. Epub 2019 Mar 18.
12 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.